Heart Failure Calculator Could Help Clinicians Personalize Combination Therapy
Aug 31, 2026
The tool is designed to address one of the biggest barriers to guideline-directed heart failure treatment: uncertainty about how individual patients will tolerate multiple therapies.
Read More –Cancer Vaccine Immunity Boosted by Oxygen-Generating Cryogel
Sep 1, 2026Tumor-on-a-Chip Can Shrink Breast Cancer Patient Drug Matching to Four Days
Aug 28, 2026Measuring ER Positivity as a Spectrum Could Improve Breast Cancer Care
Aug 26, 2026Can BriaCell Beat Merck and Moderna’s Breakthrough Personalized Melanoma Vaccine?
Aug 26, 2026‘TumorDressed’ Allogeneic Dendritic Cells Trigger Personalized Anti-Tumor Cytotoxicity
Aug 26, 2026Thymus-Sparing Strategies Deserve Consideration in NSCLC Radiotherapy Planning
Aug 26, 2026Starch Reality: Gene Therapy Gives GSD1a Patients a Metabolic Safety Net
Sep 1, 2026
Polygenic Risk Score Improves Hypertrophic Cardiomyopathy Prediction
Sep 1, 2026
EFHD1 Emerges as Potential Therapeutic Target for MASH Liver Injury
Sep 1, 2026
True Paleo Pregnancy Diet Aids Baby Brain Growth
Sep 1, 2026
AI Prenatal Risk Models Point Toward More Personalized First-Trimester Care
Aug 28, 2026
AI Can Help Improve Prognosis Prediction in Rare Heart Disease
Aug 28, 2026
News & Features
Gene-Edited CAR T Expands Rare Disease Horizons
August 01, 2026Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible
August 01, 2026Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon…
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments
August 01, 2026The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial…
Cancer Diagnostics: Droplet Digital PCR Testing for HPV+ Cancer in the Clinic
In this IPM webinar, Chad Brenner, PhD, will describe the development, validation, and clinical implementation of MyHPVscore™, a droplet digital PCR-based circulating tumor HPV DNA assay performed on the Bio-Rad QX200 platform.
Chad Brenner, PhD
Associate Professor of Otolaryngology – Head & Neck Surgery
University of Michigan
Low-Carb Diets Dramatically Alter Gut Microbiome
Aug 26, 2026Replacing carbohydrates in the diet with fat or protein radically changes the balance of microbes in the gut, with changes dependent on the substitute used.
Type 1 Diabetes Genetic Risk Score Improves MODY Diagnostic Pathway
Aug 26, 2026Incorporating a type 1 diabetes genetic risk score into routine MODY testing identified hidden type 1 diabetes in one in six unresolved cases, reducing diagnostic…
Ken Greenberg: Can Ultrasound Shatter the Gene Therapy Delivery Bottleneck?
Aug 26, 2026If its promising animal results translate to humans, SonoThera's ultrasound and microbubbles could enable larger payloads, repeat dosing, and precise tissue targeting for gene therapy.…
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
